Mosaicism, aging and cancer

Area of Science:

• Genetics
• Oncology
• Aging Research

Background:

• Genetic mosaicism involves somatic mutations in a subset of cells, distinct from germline DNA.
• Detectable genetic mosaicism is a potential early biomarker for cancer risk due to its links with aging and clonal cell expansion.
• Shared risk factors, including aging and smoking, influence both genetic mosaicism and cancer development.

Purpose of the Study:

• To review shared risk factors associated with genetic mosaicism, aging, and cancer risk.
• To explore the potential of genetic mosaicism as an early biomarker for cancer.
• To summarize current evidence linking genetic mosaicism to various cancer types.

Main Methods:

• Literature review of studies on genetic mosaicism, aging, and cancer risk.
• Analysis of associations between genetic mosaicism and cancer outcomes.
• Examination of shared risk factors across these conditions.

Main Results:

• Aging, smoking, and genetic loci are linked to increased genetic mosaicism.
• Genetic mosaicism is associated with cancer risk and mortality, though evidence strength varies.
• Strong evidence links leukocyte genetic mosaicism to hematologic malignancies.

Conclusions:

• Shared risk factors for genetic mosaicism and cancer are well-established.
• Genetic mosaicism in leukocytes is strongly linked to blood cancers.
• The connection between leukocyte mosaicism and solid tumors requires further investigation.